Skincare Stock Soars on Raised Forecast

The analysts also hiked up their price targets

Deputy Editor

Jul 2, 2020 at 10:39 AM

Nu Skin Enterprises, Inc. (NYSE:NUS) is soaring today, up 18.8% at $45.68 at last check, after the company raised its second-quarter revenue forecast, now anticipating $603 million to $608 million. Following the adjustment, two analysts upgraded the stock to "buy" -- D.A. Davidson from "neutral," with a price-target hike to $54 from $35, and Jefferies from "hold," raising its price target to $50 from $42.

Prior to today's pop, NUS was seeing pressure from the 320-day moving average at the $40 region, though it had still tripled its mid-March lows of $12.30. Currently, the stock is up 15% year-to-date following an impressive 136.7% three-month gain.

Coming into today, five out of six analysts sport a tepid "hold" rating on Nu Skin stock, with the remainder at a "sell." Meanwhile, the 12-month consensus price target of $42.29 is now a 9.6% discount to current levels, leaving plenty of room for more upgrades and price-target hikes in the near future.

Also worth noting is NUS' Schaeffer's Volatility Index (SVI) of 40%, which stands higher than just 8% of all other readings in its annual range. This implies that options players are pricing in relatively low volatility expectations at the moment.

Follow @Schaeffers

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released!